Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 6.84% | 170.81 | 0.0% | $1433.85m | |
| AMGN | Amgen, Inc. | 0.23% | 255.71 | 1.3% | $690.21m | |
| NVAX | Novavax, Inc. | 12.50% | 227.35 | 80.0% | $655.57m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -0.37% | 8.00 | 0.7% | $559.23m | |
| ILMN | Illumina, Inc. | -0.74% | 399.00 | 3.5% | $519.65m | |
| GILD | Gilead Sciences, Inc. | 1.67% | 66.87 | 1.0% | $470.50m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.61% | 502.60 | 2.7% | $458.74m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.77% | 219.39 | 1.9% | $388.60m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 3.90% | 163.68 | 2.0% | $348.10m | |
| BNTX | BioNTech SE | 7.69% | 151.54 | 0.0% | $313.57m | |
| BIIB | Biogen, Inc. | -0.05% | 270.31 | 1.7% | $263.29m | |
| EXAS | EXACT Sciences Corp. | -0.37% | 130.04 | 18.4% | $186.19m | |
| NBIX | Neurocrine Biosciences, Inc. | 1.66% | 96.58 | 4.9% | $179.73m | |
| CRSP | CRISPR Therapeutics AG | -4.27% | 118.56 | 0.6% | $166.57m | |
| SGEN | Seagen Inc. | -2.77% | 145.50 | 5.8% | $146.84m |
Company Profile
Alexion Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.